News from Abchurch

Syntopix receives Abchurch treatment

Syntopix Group plc (AIM:SYN), the speciality research and development company focused on topical antimicrobials for healthcare and pharmaceutical applications, has appointed Abchurch Communications to provide financial and corporate communications advice.

Syntopix was founded in 2003 as a spin-out from the University of Leeds by Dr Jon Cove and Dr Anne Eady, two of the world’s leading experts in skin microbiology. The Company has a robust pipeline, with a growing library of over 2,000 compounds. Its strategy is to seek to reduce the risks and costs of drug discovery and development by determining novel uses for known compounds and combinations of compounds, which have established safety profiles.

Currently, the Company’s development focus is on its three leading compounds, which have multiple potential uses across a number of large consumer healthcare markets including skincare, hair-care and oral health. Syntopix has developed strong working relationships with a number of major consumer healthcare companies including Proctor & Gamble and is now actively seeking to out-license these products to commercial partners.

Leading the Abchurch account will be Sarah Hollins, Managing Director, who heads up the Abchurch Northern office, supported by Simone Elviss.

Media enquiries:
Sarah Hollins
Managing Director
sarah.hollins@abchurch-group.com
Tel: + 44 113 203 1341